Chart-Typ:
Zeitraum:
| 3D Systems Announces Chief Financial Officer Transition | 3D Systems' Executive Vice President, Phyllis Nordstrom to Serve as Interim Chief Financial Officer ROCK HILL, S.C., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE: DDD) announced that... ► Artikel lesen |
| 3D Systems Reports Second Quarter 2025 Financial Results | ROCK HILL, S.C., Aug. 11, 2025 (GLOBE NEWSWIRE) -- 3D Systems Corporation (NYSE:DDD) announced today its financial results for the second quarter ended June 30, 2025. Revenue of $95 million led by... ► Artikel lesen |
| 3D Systems Announces Major Milestone in Digital Dentistry with Full Commercial Release of New FDA-cleared Denture Solution | Company's technology redefines dental prosthetics with revolutionary single-piece, multi-material dentures delivering distinctive combination of exquisite aesthetics, comfort and outstanding resistance... ► Artikel lesen |
| Ultimaker B.V: UltiMaker Introduces Secure Line from the S series, Defense-Grade 3D Printing for High-Security, On-Demand Production | The Secure Line transforms additive manufacturing into a frontline tactical capability across any environment.
NEW YORK and GELDERMALSEN, Netherlands, Sept. 9, 2025 /PRNewswire/ -- UltiMaker... ► Artikel lesen |
| VivoSim Labs, Inc.: VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer | SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company" or "VivoSim Labs"), a pharmaceutical and biotechnology services company that is focused on providing testing... ► Artikel lesen |
| VivoSim Labs, Inc.: VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market | SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company") announced that it has emerged from stealth mode to dramatically impact drug discovery and development.... ► Artikel lesen |
| Organovo, Inc.: Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements | SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu WELLFULLY LIMITED finden Sie auf Wallstreet Online.